The Oncotype DX Test Helps Doctors Discuss Risk with Patients

How does the Oncotype DX test help doctors discuss risk with patients?

Great advances in medical technology happen only once in a long while. The Oncotype DX test is one of these technologies. This test determines the genetic makeup of individual tumors. Doctors use this information to determine how cancers will grow and react to treatment. Every cancer is different and the Oncotype DX test helps doctors see those differences. Dr. Mark Gimbel discusses how this test has changed the way he talks to his patients in this video.

To learn more about the Oncotype DX test watch “Oncotype DX Colon Cancer Treatment Decisions” with Dr. Mark F. Kozloff.

Video Transcripts

Mark Gimbel, MD: I find that the Oncotype DX colon cancer assay does give me a more tangible way to discuss with patients. However, when actually discussing the molecular profile, most of the times the patients are not at the level to be able to understand what that means. So, it’s up to me to decide what their molecular profile actually means in terms of how they are going to go on further treatment or not.

For an interactive tool to learn more about your colon cancer and your personalized treatment options, go to MyColonCancerCoach.org.

• Bio
• Latest Posts

Mark Gimbel

Dr.Gimbel graduated from the University of Maryland, and then had an internship at the University of Florida, Jacksonville and residencies at Montefiore Medical Center/Albert Einstein College of Medicine in New York. He spent two years doing a surgical residency fellowship at Memorial Sloan Kettering Cancer Center New York and completed a surgical oncology fellowship at Moffitt Cancer Center in Tampa, Fla.

Latest posts by Mark Gimbel (see all)

• What Are Some New Treatments for Colon Cancer? - January 1, 1970
• What to Look for in a Colon Cancer Surgeon? - January 1, 1970
• The Oncotype DX Test Helps Doctors Discuss Risk with Patients - January 1, 1970